These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34033869)

  • 1. Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates.
    Nuñez-delMoral A; Brocos-Mosquera I; Vialou V; Callado LF; Erdozain AM
    Neuroscience; 2021 Jul; 467():91-109. PubMed ID: 34033869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons.
    Mongrédien R; Erdozain AM; Dumas S; Cutando L; Del Moral AN; Puighermanal E; Rezai Amin S; Giros B; Valjent E; Meana JJ; Gautron S; Callado LF; Fabre V; Vialou V
    Brain Struct Funct; 2019 Apr; 224(3):1219-1244. PubMed ID: 30656447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4.
    Weaver MS; Workman G; Cardo-Vila M; Arap W; Pasqualini R; Sage EH
    J Biol Chem; 2010 Feb; 285(8):5868-77. PubMed ID: 20018883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.
    Weaver M; Workman G; Schultz CR; Lemke N; Rempel SA; Sage EH
    J Cell Biochem; 2011 Nov; 112(11):3093-102. PubMed ID: 21688302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of SPARC/Hevin Proteins in Alzheimer's Disease Brain Injury.
    Strunz M; Jarrell JT; Cohen DS; Rosin ER; Vanderburg CR; Huang X
    J Alzheimers Dis; 2019; 68(2):695-710. PubMed ID: 30883351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder.
    Nuñez-delMoral A; Bianchi PC; Brocos-Mosquera I; Anesio A; Palombo P; Camarini R; Cruz FC; Callado LF; Vialou V; Erdozain AM
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC.
    Kucukdereli H; Allen NJ; Lee AT; Feng A; Ozlu MI; Conatser LM; Chakraborty C; Workman G; Weaver M; Sage EH; Barres BA; Eroglu C
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):E440-9. PubMed ID: 21788491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between hevin, SPARC, and MDGAs: Modulators of neurexin-neuroligin transsynaptic bridges.
    Fan S; Gangwar SP; Machius M; Rudenko G
    Structure; 2021 Jul; 29(7):664-678.e6. PubMed ID: 33535026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family.
    Sullivan MM; Sage EH
    Int J Biochem Cell Biol; 2004 Jun; 36(6):991-6. PubMed ID: 15094114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.
    Aroca-Aguilar JD; Sánchez-Sánchez F; Ghosh S; Fernández-Navarro A; Coca-Prados M; Escribano J
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):179-89. PubMed ID: 20926826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the synaptic molecules Hevin and SPARC in mouse neuromuscular junction development and repair.
    Brayman VL; Taetzsch T; Miko M; Dahal S; Risher WC; Valdez G
    Neurosci Lett; 2021 Feb; 746():135663. PubMed ID: 33493647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hevin-calcyon interaction promotes synaptic reorganization after brain injury.
    Kim JH; Jung HG; Kim A; Shim HS; Hyeon SJ; Lee YS; Han J; Jung JH; Lee J; Ryu H; Park JY; Hwang EM; Suk K
    Cell Death Differ; 2021 Sep; 28(9):2571-2588. PubMed ID: 33753902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autism-associated mutation in Hevin/Sparcl1 induces endoplasmic reticulum stress through structural instability.
    Taketomi T; Yasuda T; Morita R; Kim J; Shigeta Y; Eroglu C; Harada R; Tsuruta F
    Sci Rep; 2022 Jul; 12(1):11891. PubMed ID: 35831437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins.
    Brekken RA; Sullivan MM; Workman G; Bradshaw AD; Carbon J; Siadak A; Murri C; Framson PE; Sage EH
    J Histochem Cytochem; 2004 Jun; 52(6):735-48. PubMed ID: 15150282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates.
    Brocos-Mosquera I; Nuñez Del Moral A; Morentin B; Meana JJ; Callado LF; Erdozain AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():236-242. PubMed ID: 28941770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.
    Barker TH; Framson P; Puolakkainen PA; Reed M; Funk SE; Sage EH
    Am J Pathol; 2005 Mar; 166(3):923-33. PubMed ID: 15743803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
    J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hevin/Sparcl1 drives pathological pain through spinal cord astrocyte and NMDA receptor signaling.
    Chen G; Xu J; Luo H; Luo X; Singh SK; Ramirez JJ; James ML; Mathew JP; Berger M; Eroglu C; Ji RR
    JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36256481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of myocilin with the C-terminal region of hevin.
    Li Y; Aroca-Aguilar JD; Ghosh S; Sánchez-Sánchez F; Escribano J; Coca-Prados M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):797-804. PubMed ID: 16316624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARCL1 a novel player in cancer biology.
    Gagliardi F; Narayanan A; Mortini P
    Crit Rev Oncol Hematol; 2017 Jan; 109():63-68. PubMed ID: 28010899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.